Resveratrol Suppresses Cardiac Renin Angiotensin System in the Late Phase of Left Ventricular Hypertrophy
<strong>Background</strong> <strong>and objectives:</strong> Resveratrol(3,5,4′-trihydroxy-trans-stilbene) is a natural polyphenole phytoalexin which exerts potential cardioprotective effects, but the cellular and molecular mechanisms responsible for these effects are still u...
Main Authors: | Tahmineh Hashemizadeh, Ali Pedarzadeh, Aryan Naghedi, Fahimeh Dorri Mashhadi, Javad Zavvar Reza, Fereshteh Safari, Fatemeh Safari* |
---|---|
Format: | Article |
Language: | English |
Published: |
Iranian Society of Pharmacognosy
2019-04-01
|
Series: | Research Journal of Pharmacognosy |
Subjects: | |
Online Access: | http://www.rjpharmacognosy.ir/article_84316_cccc7e6a2183260e7e27e41511c94f4a.pdf |
Similar Items
-
Left ventricular hypertrophy: renin4angiotensin system role
by: F. T. Ageev, et al.
Published: (2008-04-01) -
Left ventricular hypertrophy and renin-angiotensin-aldosterone system: AT1-receptor blockers are in the focus
by: A V Barsukov, et al.
Published: (2013-03-01) -
Association Between the Angiotensin II/Angiotensin (1-7) Imbalance and Left Ventricular Hypertrophy in Patients with Heart Failure
by: Nikolov A., et al.
Published: (2021-10-01) -
The Effect of FGF23 on Cardiac Hypertrophy Is Not Mediated by Systemic Renin-Angiotensin- Aldosterone System in Hemodialysis
by: Katharina Dörr, et al.
Published: (2022-04-01) -
MicroRNAs Regulating Renin–Angiotensin–Aldosterone System, Sympathetic Nervous System and Left Ventricular Hypertrophy in Systemic Arterial Hypertension
by: Alex Cleber Improta-Caria, et al.
Published: (2021-11-01)